Abstract
62 - Real-world dosage, tolerability and clinical outcomes in patients with squamous NSCLC treated with carboplatin, paclitaxel and pembrolizumab in the West of Scotland
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
